Compounds / GH Axis / Hexarelin

Hexarelin

Hexarelin (Examorelin — Hexapeptide GHRP)

GH AxisWell ResearchedFDA: Not approvedWADA: PROHIBITED — Category S2

Overview

Unique dual mechanism: GH secretagogue + cardiac protection via CD36. Cardioprotective effects studied independently of GH axis. Faster receptor desensitization limits long-term use.

Mechanism of Action

Potent GHS-R1a agonist. Unique CARDIOPROTECTIVE properties via CD36 receptor in cardiac tissue — independent of GH release. Anti-fibrotic effects. Highest GH-releasing potency among GHRPs but desensitizes faster.

Pharmacokinetics

Half-life

1 hr

Peak (Tmax)

30 min

Cleared

~5 hrs

Molecular Profile

Molecular weight

887.04 Da

CAS number

140703-51-1

Type

Synthetic hexapeptide (GHRP)

Length

6 amino acids

Key Research Findings

Cardioprotective via CD36; anti-fibrotic; highest GHRP potency; faster desensitization; unique cardiac application.

Published Research

Eur J Pharmacol (1997)

Torsello A et al. Hexarelin analogs: a new family of growth hormone releasing peptides

View source

J Endocrinol (1998)

Torsello A et al. Hexarelin activates specific binding sites in rat heart

View source

Related GH Axis Compounds

Ipamorelin CJC-1295 (No DAC)CJC-1295 (DAC)Sermorelin Tesamorelin GHRP-2

Clinical Guidance

Research data is not a treatment plan. If you are considering Hexarelin, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.

Running Hexarelin? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator · Full deep dive · Peptide fundamentals